Covered recipient · General Payments record
PAUL L DUDLEY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$3,886.22
- Reported across 151 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $505.66 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $145.86 | 8 |
| PFIZER INC. | $61.58 | 3 |
| Neurelis, Inc. | $59.08 | 2 |
| SK Life Science, Inc. | $41.22 | 2 |
| Azurity Pharmaceuticals, Inc. | $33.42 | 2 |
| ARGENX US, INC. | $29.78 | 1 |
| Kyowa Kirin, Inc. | $27.91 | 1 |
| EISAI INC. | $25.55 | 1 |
| Teva Pharmaceuticals USA, Inc. | $23.81 | 1 |
| Lundbeck LLC | $23.05 | 1 |
| Merz Pharmaceuticals, LLC | $20.96 | 1 |
| Acorda Therapeutics, Inc | $13.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.47 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663740 | CMS |
| ABBVIE INC. | $23.64 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663742 | CMS |
| ABBVIE INC. | $7.10 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663744 | CMS |
| ABBVIE INC. | $30.19 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663746 | CMS |
| ABBVIE INC. | $10.08 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663748 | CMS |
| ABBVIE INC. | $33.88 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663750 | CMS |
| ABBVIE INC. | $8.23 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663752 | CMS |
| ABBVIE INC. | $20.27 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103663754 | CMS |
| Acorda Therapeutics, Inc | $13.44 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142349516 | CMS |
| ARGENX US, INC. | $29.78 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142120393 | CMS |
| Azurity Pharmaceuticals, Inc. | $15.76 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134005255 | CMS |
| Azurity Pharmaceuticals, Inc. | $17.66 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134005257 | CMS |
| Eisai Inc. | $25.55 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110771929 | CMS |
| Kyowa Kirin, Inc. | $27.91 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127040049 | CMS |
| Lundbeck LLC | $23.05 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145912061 | CMS |
| Merz Pharmaceuticals, LLC | $20.96 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137953506 | CMS |
| Neurelis, Inc. | $35.95 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145640539 | CMS |
| Neurelis, Inc. | $23.13 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145640541 | CMS |
| PFIZER INC. | $17.26 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131744594 | CMS |
| PFIZER INC. | $28.47 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132084978 | CMS |
| PFIZER INC. | $15.85 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131486877 | CMS |
| SK Life Science, Inc. | $17.11 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154110611 | CMS |
| SK Life Science, Inc. | $24.11 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154110741 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.81 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151615092 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.